Similar articles

• Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping.

  Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, Barnett AH. Todd JA, et al. Nature. 1989 Apr 13;338(6216):587-9. doi: 10.1038/338587a0. Nature. 1989. PMID: 2494458
• Susceptibility to type I diabetes: HLA-DQ and DR revisited.

  She JX. She JX. Immunol Today. 1996 Jul;17(7):323-9. doi: 10.1016/0167-5699(96)10014-1. Immunol Today. 1996. PMID: 8763818 Review. No abstract available.
• HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.

  Robinson DM, Holbeck S, Palmer J, Nepom GT. Robinson DM, et al. Genet Epidemiol. 1989;6(1):149-54. doi: 10.1002/gepi.1370060128. Genet Epidemiol. 1989. PMID: 2567255
• [Mechanism and genetic control of the autoimmune response directed against beta-pancreatic cells in insulin-dependent diabetes].

  Michelsen B, Baekkeskov S, Deufel T, Kastern W, Kofod H, Lernmark A, Vissing H. Michelsen B, et al. Journ Annu Diabetol Hotel Dieu. 1985:171-82. Journ Annu Diabetol Hotel Dieu. 1985. PMID: 2577960 Review. French. No abstract available.
• High risk HLA-DR/DQ genotypes for IDD confer susceptibility to autoantibodies but DQB1*0602 does not prevent them.

  Huang W, She JX, Muir A, Laskowska D, Zorovich B, Schatz D, Maclaren NK. Huang W, et al. J Autoimmun. 1994 Dec;7(6):889-97. doi: 10.1006/jaut.1994.1073. J Autoimmun. 1994. PMID: 7888045